Its a collaborative trial Mangoman. I am sure J&J wrote some conditions of exclustivity into the contract, but exactly what we will never know. But its a collaboration so J&J must have some exclusitivity. I think its been forgotten over the years (these trials do take years at the best of time, then throw in COVID) that this is a collaborative trial with J&J as involved as OCC - just with domestic surgeons running the practicalities.
"Regenerative medicine company Orthocell Limited has today announced a research collaboration agreement with DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of Companies, for its Ortho-ATI® stem cell approach for the regeneration of degenerate tendons and ligaments. The collaboration was facilitated by Johnson & Johnson Innovation." (2017)
We should get the final data next week. I wouldn't expect a partnership to be announced with it, but that will hopefully follow. We know the stock consistently spikes on trial announcements of course.
- Forums
- ASX - By Stock
- OCC Trading
Its a collaborative trial Mangoman. I am sure J&J wrote some...
-
- There are more pages in this discussion • 736 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
40.0¢ |
Change
0.010(2.56%) |
Mkt cap ! $83.83M |
Open | High | Low | Value | Volume |
39.0¢ | 40.0¢ | 39.0¢ | $199.1K | 504.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3807 | 39.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 3666 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3807 | 0.390 |
2 | 7793 | 0.385 |
3 | 27634 | 0.380 |
2 | 42700 | 0.375 |
4 | 23903 | 0.370 |
Price($) | Vol. | No. |
---|---|---|
0.400 | 3666 | 2 |
0.405 | 74300 | 2 |
0.410 | 45237 | 4 |
0.420 | 135239 | 3 |
0.425 | 39350 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |